The acquisition grows Stryker’s soft tissue fixation portfolio, according to a June 3 news release. Artelon’s products have technology designed to enhance biological and mechanical ligament and tendon reconstruction, and have been used in more than 60,000 cases worldwide.
The transaction is subject to customary closing conditions. Terms of the deal weren’t disclosed.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
